Contact Us 
The Styrian company RobotDreams is developing a highly innovative, AI-powered diagnostic platform with a clear vision: AI-based blood diagnostics should become the global standard for almost all clinical pictures in the future. At its core is a powerful, trained AI model that differentiates clinical conditions with exceptional accuracy – with AUROC values of over 90%.
The first diagnostic module focuses on predicting Acute Coronary Syndrome (ACS) – one of the most common and critical causes of hospital admissions worldwide. Further modules for the early detection of heart failure (HF) and coronary artery disease (CAD) are already under development. In the long term, RobotDreams plans to expand into other specialties such as nephrology, hepatology, neurology, and pulmonology – with the goal of fundamentally transforming laboratory medicine.
Precision Meets Clinical Expertise
The technology combines state-of-the-art machine learning with in-depth clinical expertise. Blood data is analyzed using AI to identify diseases early, quickly, and precisely – a crucial advantage in emergency and preventive medicine.
Parallel to technological development, RobotDreams is intensively working on patent applications, clinical studies, as well as CE marking and IVDR certification. These regulatory steps are essential to meet the highest quality and safety standards and to ensure sustainable market launch in the European healthcare sector.
